Characterizing the Impact of Spray Dried Particle Morphology on Tablet Dissolution Using Quantitative X-Ray Microscopy.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
PMID:

Abstract

For oral solid dosage forms, disintegration and dissolution properties are closely related to the powders and particles used in their formulation. However, there remains a strong need to characterize the impact of particle structures on tablet compaction and performance. Three-dimensional non-invasive tomographic imaging plays an increasingly essential role in the characterization of drug substances, drug product intermediates, and drug products. It can reveal information hidden at the micro-scale which traditional characterization approaches fail to divulge due to a lack of resolution. In this study, two batches of spray-dried particles (SDP) and two corresponding tablets of an amorphous product, merestinib (LY2801653), were analyzed with 3D X-Ray Microscopy. Artificial intelligence-based image analytics were used to quantify physical properties, which were then correlated with dissolution behavior. The correlation derived from the image-based characterization was validated with conventional laboratory physical property measurements. Quantitative insights obtained from image-analysis including porosity, pore size distribution, surface area and pore connectivity helped to explain the differences in dissolution behavior between the two tablets, with root causes traceable to the microstructure differences in their corresponding SDPs.

Authors

  • Shawn Zhang
    DigiM Solution LLC, Burlington, MA 01803, USA.
  • Paul A Stroud
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States. Electronic address: stroud_paul_andrew@lilly.com.
  • Aiden Zhu
    DigiM Solution LLC, Burlington, MA 01803, USA.
  • Michael J Johnson
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States.
  • Joshua Lomeo
    DigiM Solution LLC, 67 South Bedford Street, Suite 400 West, Burlington, MA 01803, United States.
  • Christopher L Burcham
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States.
  • Jeremy Hinds
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States.
  • Kyle Allen-Francis Blakely
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States.
  • Matthew J Walworth
    Eli Lilly & Company, 1400 W. Raymond Street, Indianapolis, IN United States.